SEC Form 4 · accession 0001209191-15-049589
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua S Boger
Director
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $127.54 | Jun 1, 2015 | A | 20,000 | A | Jun 1, 2015 | May 31, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Fully vested.